Similar to the miR-29a/29b-1 cluster, miR-107 down-regulation has been observed in mild cognitive impairment (MCI), an early stage of AD; BACE1 has been shown to be a major miR-107 target site [28]. Here, BACE1 is linked to Alzheimer disease.